2024
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Bikdeli B, Sadeghipour P, Lou J, Bejjani A, Khairani C, Rashedi S, Lookstein R, Lansky A, Vedantham S, Sobieszczyk P, Mena-Hurtado C, Aghayev A, Henke P, Mehdipoor G, Tufano A, Chatterjee S, Middeldorp S, Wasan S, Bashir R, Lang I, Shishehbor M, Gerhard-Herman M, Giri J, Menard M, Parikh S, Mazzolai L, Moores L, Monreal M, Jimenez D, Goldhaber S, Krumholz H, Piazza G. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review. Seminars In Thrombosis And Hemostasis 2024, 50: 851-865. PMID: 38176425, DOI: 10.1055/s-0043-1777991.Peer-Reviewed Original ResearchVena cava interruptionDeep vein thrombosisInferior vena cavaVena cava filtersVenous thromboembolismPulmonary embolismVena cavaCava filtersProcedural interruptionsRisk of DVTBilateral deep vein thrombosisInfrarenal inferior vena cavaAcute venous thromboembolismLong-term complicationsSystemic adverse effectsSystemic venous circulationHigh-quality evidenceSuperior vena cavaMeta-Analyses (PRISMA) guidelinesPreferred Reporting ItemsIVC agenesisVein thrombosisYounger patientsThrombotic eventsRight atrium
2022
PREDICTORS OF POOR OUTCOMES AMONG PATIENTS UNDERGOING CATHETER-DIRECTED THROMBOLYSIS FOR DEEP VEIN THROMBOSIS
Bhalla A, Ahmed Z, Mena-Hurtado C, Attaran R. PREDICTORS OF POOR OUTCOMES AMONG PATIENTS UNDERGOING CATHETER-DIRECTED THROMBOLYSIS FOR DEEP VEIN THROMBOSIS. Journal Of The American College Of Cardiology 2022, 79: 803. DOI: 10.1016/s0735-1097(22)01794-6.Peer-Reviewed Original Research
2019
Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion
Attaran RR, Ozdemir D, Lin IH, Mena-Hurtado C, Lansky A. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2019, 7: 527-534. PMID: 31203859, DOI: 10.1016/j.jvsv.2019.01.058.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnticoagulantsEndovascular ProceduresFemaleHumansIliac VeinMaleMay-Thurner SyndromeMiddle AgedPlatelet Aggregation InhibitorsPostthrombotic SyndromeProsthesis DesignRecurrenceRetrospective StudiesStentsTime FactorsTreatment OutcomeVascular PatencyVena Cava, InferiorVenous ThrombosisConceptsAcute deep vein thrombosisPost-thrombotic syndromeDeep vein thrombosisMay-Thurner syndromeDuration of anticoagulationAntiplatelet therapyPatency ratesIliocaval stentingIpsilateral deep vein thrombosisIliocaval venous stentingPrimary patency rateStent patency ratesCommon femoral veinVariety of indicationsLarge teaching hospitalVein thrombosisVenous stentingRetrospective reviewDVT groupStent groupFemoral veinProcedural dataStent patencyStent occlusionTeaching hospitalEndovascular Treatment of Inferior Vena Cava Thrombosis in Metastatic Malignancy: A Case Report and Review of Literature
Shapero KS, Jelani QU, Mena C. Endovascular Treatment of Inferior Vena Cava Thrombosis in Metastatic Malignancy: A Case Report and Review of Literature. Vascular And Endovascular Surgery 2019, 53: 507-511. PMID: 31216954, DOI: 10.1177/1538574419857992.Peer-Reviewed Original ResearchConceptsInferior vena cava thrombosisLower extremity edemaVena cava thrombosisAcute liver failureRight atriumIVC thrombosisCava thrombosisExtremity edemaLiver failureSevere bilateral lower extremity edemaBilateral lower extremity edemaAdrenal cell carcinomaExtensive clot burdenExtensive IVC thrombosisMetastatic liver massesDeep vein thrombosisClot burdenIVC syndromeReview of literatureGastrointestinal bleedHospital courseVein thrombosisHepatic failureCaudate lobeEndovascular treatment